Acasti Pharma, Inc.

Q4 2023 13F Holders

Symbol
ACST
CUSIP
00430K865
Type
Equity
Class
CL A
Num filings
11
Total reported value, excl. options
$1.66 M
Manager Report Date Value ($000) Shares Option Type